Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 23 locations
View Trial Details
Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NCT07503808

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +48 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START New York Long Island, LLC Lake Success, New York, United States
View all 15 locations
View Trial Details
Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06586515

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 52 locations
View Trial Details
Recruiting

A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib

NCT07164170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 17 locations
View Trial Details
Recruiting

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NCT05786924

Conditions
Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
View all 27 locations
View Trial Details

Related conditions